Yifan Pharmaceutical’s subsidiary buys Amyris’ interests
Summary: Hangzhou Xinfu, a wholly-owned subsidiary of Yifan Pharmaceutical, has agreed to pay Amyris USD50 million in order to have certain interests Amyris obtains from DSM, which has been authorised to use Amyris' patent and invention about farnese...
Vitamins China E-News 201901